Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Sphingomyelin (SPH) ELISA Kit-Competitive

Cat. No.EK1F761

Product TypeAnimal Immunoassay Kits

Size 96T

Product Overview

BioVenic Canine Sphingomyelin (SPH) ELISA Kit-Competitive is designed for the quantitative determination of Canine Sphingomyelin (SPH) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Competitive ELISA method. For research use only.

Specifications

Assay Type ELISA-Competitive
Specificity The assay kit is specific for Canine SPH.
Target Species Canine
Species Reactivity Canine
Detection Range 6.26-400 μg/mL
Sensitivity 1.85 μg/mL
Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%
Assay Time Around 120 min
Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids.

Target Information

Sphingomyelin is a type of sphingolipid which is found in animal cell membranes, especially in the membranous myelin sheath that surrounds some nerve cell axons. It is one of the few membrane phospholipids not synthesized from glycerol. It plays significant roles in signaling pathways, cell structure, and cell metabolism. The main function of epidermal sphingolipids in the stratum corneum of the epidermis is the formation of the skin barrier and the regulation of transepidermal water loss.

Target/Biomarker Canine SPH
Target Synonym SM

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Marsella, R. et al. Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitis. BMC Vet Res. 2020, 16: 92.
Inquiry Basket